Kyowa Kirin North America is a specialty pharmaceutical company focused on developing and commercializing innovative medicines to meet the needs of patients with rare diseases and unmet medical needs. They generate revenue through the research, development, and sale of prescription medications, particularly in the fields of oncology, nephrology, and immunology. The company is a subsidiary of Kyowa Kirin Co., Ltd., a leading Japanese pharmaceutical firm with a rich history dating back to 1949, known for its pioneering work in biotechnology and antibody research.